SREBF2 and metabolic dysfunction-associated steatohepatitis: In a study conducted in patients diagnosed with MASH and those diagnosed with simple steatosis only, a significantly higher expression of SREBP-2 was observed in patients with MASH and fibrosis compared to those with or without steatosis [128,129].